Compare GH & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | CCK |
|---|---|---|
| Founded | 2011 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 11.4B |
| IPO Year | 2018 | 2003 |
| Metric | GH | CCK |
|---|---|---|
| Price | $85.12 | $98.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 15 |
| Target Price | $117.80 | ★ $123.27 |
| AVG Volume (30 Days) | ★ 1.7M | 840.1K |
| Earning Date | 04-29-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | 6.74 | ★ 79.72 |
| EPS | N/A | ★ 6.38 |
| Revenue | $982,021,000.00 | ★ $11,665,000,000.00 |
| Revenue This Year | $33.40 | $5.26 |
| Revenue Next Year | $28.55 | $2.40 |
| P/E Ratio | ★ N/A | $15.81 |
| Revenue Growth | ★ 32.88 | N/A |
| 52 Week Low | $36.36 | $75.98 |
| 52 Week High | $120.74 | $116.62 |
| Indicator | GH | CCK |
|---|---|---|
| Relative Strength Index (RSI) | 34.90 | 27.38 |
| Support Level | $82.26 | $94.24 |
| Resistance Level | $103.16 | $98.83 |
| Average True Range (ATR) | 3.94 | 2.41 |
| MACD | 0.07 | -1.16 |
| Stochastic Oscillator | 20.02 | 3.33 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.